Ethylene glycol monomethyl ether

• Identification
• Experimental evidence
• Physicochemical properties
• ADMET properties
• Chemical-gene interaction
• Descriptors
• Presence in chemical regulation or guideline
• Presence in human biospecimen

Literature identifier	Study type	Test dosage	Effective dosage	Endocrine-mediated endpoints	Systems-level perturbations
PMID:1288759	IVR	250 mg/kg/day	250 mg/kg/day	Affects spermatogenesis	Reproductive endocrine-mediated perturbations
PMID:4065311	IVR	250 mg/kg	250 mg/kg	Affects spermatogenesis	Reproductive endocrine-mediated perturbations
PMID:6499822	IVR	62.5 mg/kg	62.5 mg/kg	Affects skeletal development in fetus	Developmental endocrine-mediated perturbations
	IVR	62.5 mg/kg	62.5 mg/kg	Affects skeletal development	Developmental endocrine-mediated perturbations
	IVR	250 mg/kg	250 mg/kg	Affects skeletal development in fetus	Developmental endocrine-mediated perturbations
	IVR	250 mg/kg	250 mg/kg	Testicular atrophy	Reproductive endocrine-mediated perturbations
	IVR	250 mg/kg	250 mg/kg	Affects skeletal development	Developmental endocrine-mediated perturbations
	IVR	250 mg/kg	250 mg/kg	Increased testis weights	Reproductive endocrine-mediated perturbations
	IVR	250 mg/kg	250 mg/kg	Affects developmental process	Developmental endocrine-mediated perturbations
	IVR	1000 mg/kg	1000 mg/kg	Affects survival of live fetus	Reproductive endocrine-mediated perturbations
	IVR	500 mg/kg	500 mg/kg	Affects developmental process	Developmental endocrine-mediated perturbations
	IVR	500 mg/kg	500 mg/kg	Affects skeletal development	Developmental endocrine-mediated perturbations
	IVR	500 mg/kg	500 mg/kg	Affects skeletal development in fetus	Developmental endocrine-mediated perturbations
	IVR	500 mg/kg	500 mg/kg	Increased testis weights	Reproductive endocrine-mediated perturbations
	IVR	500 mg/kg	500 mg/kg	Changes in haemocrit values	Immunological endocrine-mediated perturbations
	IVR	500 mg/kg	500 mg/kg	Testicular atrophy	Reproductive endocrine-mediated perturbations
	IVR	125 mg/kg	125 mg/kg	Affects skeletal development in fetus	Developmental endocrine-mediated perturbations
	IVR	125 mg/kg	125 mg/kg	Affects skeletal development	Developmental endocrine-mediated perturbations
	IVR	125 mg/kg	125 mg/kg	Affects developmental process	Developmental endocrine-mediated perturbations
	IVR	125 mg/kg	125 mg/kg	Increased testis weights	Reproductive endocrine-mediated perturbations
	IVR	125 mg/kg	125 mg/kg	Testicular atrophy	Reproductive endocrine-mediated perturbations

---

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.